Edmonton – October 05, 2026 -- Aurora Cannabis Inc. (TSX: ACB; NASDAQ: ACB) confirmed that Curaleaf Holdings, Inc. has yet to file a formal Notice of Variation and Change despite announcing intent to revise its hostile takeover bid to an implied US$5.00 per share, comprising 0.4013 Curaleaf subordinate voting shares plus US$1.00 cash per Aurora share.

Aurora says no formal offer has been received for review

Miguel Martin, Executive Chairman and CEO of Aurora, said the company has not yet obtained the materials needed to conduct a full evaluation of the revised terms. The Special Committee of independent directors will apply the same rigorous, independent process used for the original bid once formal documentation is filed. Aurora reiterated that shareholders should take no action and await the Board's recommendation, which will be issued via news release and Directors' Circular within 15 days of receiving the formal revised bid, as required under securities law.

Regulatory complaint forces Curaleaf to extend deadline and add disclosures

Aurora's application to the Alberta Securities Commission identified deficiencies in Curaleaf's original circular, including the absence of pro forma financial statements and a deposit period shorter than the legal minimum. Curaleaf has now agreed to amend its circular to include the required pro forma financials and extend the Hostile Bid's expiry to 11:59 p.m. Mountain Time on December 4, 2026, giving Aurora shareholders until at least that date to evaluate the offer.

Shareholders told to hold off following September 2 recommendation

Aurora's Board had previously advised shareholders on September 2, 2026 to take no action on the Hostile Bid. That guidance remains in effect pending the Special Committee's review of any formally filed revised terms. Aurora shareholders with questions have been directed to the company's strategic advisor and information agent, Kingsdale Advisors.